Use of vitamin K antagonists for secondary stroke prevention depends on the treating healthcare provider in Germany – results from the German AFNET registry

BACKGROUND: Anticoagulation using vitamin K antagonists (VKAs) significantly reduces the risk of recurrent stroke in stroke patients with atrial fibrillation (AF) and is recommended by guidelines. METHODS: The German Competence NETwork on Atrial Fibrillation established a nationwide prospective regi...

Descripción completa

Detalles Bibliográficos
Autores principales: Haeusler, Karl Georg, Gerth, Andrea, Limbourg, Tobias, Tebbe, Ulrich, Oeff, Michael, Wegscheider, Karl, Treszl, András, Ravens, Ursula, Meinertz, Thomas, Kirchhof, Paulus, Breithardt, Günter, Steinbeck, Gerhard, Nabauer, Michael
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2015
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4524411/
https://www.ncbi.nlm.nih.gov/pubmed/26242880
http://dx.doi.org/10.1186/s12883-015-0371-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4524411/
https://www.ncbi.nlm.nih.gov/pubmed/26242880
http://dx.doi.org/10.1186/s12883-015-0371-8

Ejemplares similares